Journal: Journal of Translational Medicine
Article Title: Triple-remodeling of tumor microenvironment through hyaluronidase-assisted folate-targeted lipid nanoparticle-mediated siVEGF/siPD-L1 for enhanced tumor immunotherapy
doi: 10.1186/s12967-026-07697-y
Figure Lengend Snippet: Anti-tumor immune mechanism study of FA-LNPs and FA-LNPvp. ( A ) H&E and immunofluorescence analyses of tumor tissue sections, H&E staining, cell proliferation marker Ki67, CD4⁺ T cells (red), and CD8⁺ T cells (green). Scale bars = 100 μm for H&E, 20 μm for Ki67 and CD4/CD8 immunofluorescence. Gene expression analysis in tumor tissues by RT-qPCR, ( B ) VEGF-A mRNA, ( C ) PD-L1 mRNA, and ( D ) HAase mRNA levels. Flow cytometric quantification of tumor-infiltrating immune cells, ( E ) CD3⁺CD4⁺ T cells, ( F ) CD3⁺CD8⁺ T cells, ( G ) CD11b⁺CD80⁺F4/80⁺ M1 macrophages, and ( H ) CD11b⁺Gr1⁺ M2 macrophages. Serum cytokine concentrations by ELISA, ( I ) IL-6, ( J ) TNF-α, and (K) IFN-γ levels in mouse serum. Results were expressed as means ± SD ( n = 6). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
Article Snippet: An anti-PD-L1 recombinant monoclonal antibody was purchased from BioXcell, Inc. (West Lebanon, NH, USA).
Techniques: Immunofluorescence, Staining, Marker, Gene Expression, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay